Prostate-Specific Antigen (PSA) is a serine protease of the kallikrein family, that is produced by the prostate epithelium and epithelial lining of the periurethral glands. Although considered prostate-specific, PSA has also been detected in breast tissue, breast tumors, endometrium, adrenal neoplasms, and renal cell carcinomas. Anti-PSA can be used for differentiating high-grade prostate adenocarcinoma from high-grade urothelial carcinoma, as well as for determining the prostatic origin of carcinomas in non-prostate tissues. Anti-PSA recognizes primary and metastatic prostatic neoplasms, but not tumors of nonprostatic origin, and can be useful as an aid to confirm prostatic acinar cell origin in primary and metastatic carcinomas.
0.1 ml Concentrate - IHC654-100
1.0 ml Concentrate - IHC564-1
7.0 ml Pre-Dilute - IHC564-7
Source Mouse Monoclonal Positive Control Prostate, Prostate Carcinoma Dilution Range 1:50-1:200
- Polascik TJ, et al. J Urol. 1999; 162:293-306.
- Stenman UH, et al. Semin Cancer Biol. 1999; 9:83-93.
- Alanen KA, et al. Path Res Pract. 1996; 192:233-7.
- Varma M, et al. Histopathology. 2005; 47:1-16.
- Gallee MP, et al. Prostate. 1986; 9:33-45.
- Hadji M, et al. Cancer. 1981; 48:1229-32.
- Tazawa K, et. al. Path Intl. 1999; 49:500-5.
- Siddiqui IA, et. al. Carcinogenesis. 2006; 27:833-9.
- Ljung G, et. al. Prostate. 1997; 31:91-7.